Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIMPP: Lidocaine Infusion Following Major Reconstructive Spine Surgery
NCT05010148Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- Sep 2021
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative delirium (POD), postoperative pain, sponsored by University of California, San Francisco. Started Sep 2021; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative delirium (POD)postoperative pain
Beyond the preview
Go deeper on NCT05010148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05010148.